| |
| |
|
| Insider
Information: |
Wilson Troy Edward |
| Relationship: |
Director |
| City: |
Los Angeles |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
93,642 |
|
|
Indirect Shares
|
974,552 |
|
|
| Direct
Value |
$1,676,818 |
|
|
|
Indirect Value
|
$21,001,446 |
|
|
| Total
Shares |
1,068,194 |
|
|
| Total
Value |
$22,678,264 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -67.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Puma Biotechnology Inc |
PBYI |
Director |
2023-06-13 |
27,350 |
2023-06-13 |
550 |
Premium* |
|
|
Kura Oncology Inc |
KURA |
|
2024-01-24 |
559 |
2024-01-24 |
579,194 |
Premium* |
|
|
Zosano Pharma Corp |
ZSAN |
Director |
2015-04-01 |
3,000 |
2015-04-01 |
0 |
Premium* |
|
|
Avidity Biosciences, Inc. |
RNA |
Director |
2023-12-12 |
62,733 |
2023-12-12 |
394,808 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KURA |
Kura Oncology Inc |
President and CEO |
• • – |
2024-01-24 |
4 |
AS |
$20.23 |
$1,841,982 |
D/D |
(91,052) |
559 |
0 |
% |
|
| KURA |
Kura Oncology Inc |
President and CEO |
• • – |
2024-01-24 |
4 |
OE |
$4.80 |
$550,594 |
D/D |
91,052 |
84,666 |
0 |
- |
|
| RNA |
Avidity Biosciences, Inc. |
Director |
– • – |
2023-12-12 |
4 |
A |
$0.00 |
$0 |
I/I |
550,000 |
300,000 |
0 |
- |
|
| RNA |
Avidity Biosciences, Inc. |
Director |
– • – |
2023-12-12 |
4 |
D |
$0.00 |
$0 |
I/I |
(550,000) |
13,711 |
0 |
- |
|
| KURA |
Kura Oncology Inc |
President and CEO |
• • – |
2023-12-07 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,000 |
279,194 |
0 |
- |
|
| KURA |
Kura Oncology Inc |
President and CEO |
• • – |
2023-12-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,000 |
559 |
0 |
- |
|
| PBYI |
Puma Biotechnology Inc |
Director |
• • – |
2023-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
27,000 |
27,350 |
0 |
- |
|
| PBYI |
Puma Biotechnology Inc |
Director |
• • – |
2023-06-13 |
4 |
AS |
$3.45 |
$93,269 |
D/D |
(27,000) |
350 |
0 |
% |
|
| KURA |
Kura Oncology Inc |
President and CEO |
• • – |
2023-06-02 |
4 |
D |
$0.00 |
$0 |
I/I |
(862,212) |
280,194 |
0 |
- |
|
| KURA |
Kura Oncology Inc |
President and CEO |
• • – |
2023-06-02 |
4 |
A |
$0.00 |
$0 |
I/I |
308,394 |
300,000 |
0 |
- |
|
| KURA |
Kura Oncology Inc |
President and CEO |
• • – |
2023-06-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(27,966) |
2,559 |
0 |
- |
|
| KURA |
Kura Oncology Inc |
President and CEO |
• • – |
2022-10-06 |
4 |
A |
$0.00 |
$0 |
I/I |
1,084,300 |
1,125,618 |
0 |
- |
|
| KURA |
Kura Oncology Inc |
President and CEO |
• • – |
2022-10-06 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,084,300) |
8,394 |
0 |
- |
|
| KURA |
Kura Oncology Inc |
President and CEO |
• • – |
2022-08-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(11,985) |
30,525 |
0 |
- |
|
| KURA |
Kura Oncology Inc |
President and CEO |
• • – |
2022-08-19 |
4 |
A |
$0.00 |
$0 |
I/I |
41,318 |
41,318 |
0 |
- |
|
| KURA |
Kura Oncology Inc |
President and CEO |
• • – |
2022-08-19 |
4 |
D |
$0.00 |
$0 |
I/I |
(59,026) |
1,092,694 |
0 |
- |
|
| KURA |
Kura Oncology Inc |
President and CEO |
• • – |
2022-07-14 |
4 |
D |
$0.00 |
$0 |
I/I |
(468,297) |
1,151,720 |
0 |
- |
|
| PBYI |
Puma Biotechnology Inc |
Director |
• • – |
2022-06-16 |
4 |
AS |
$2.58 |
$71,971 |
D/D |
(27,858) |
27,350 |
0 |
% |
|
| PBYI |
Puma Biotechnology Inc |
Director |
• • – |
2022-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
27,000 |
55,208 |
0 |
- |
|
| PBYI |
Puma Biotechnology Inc |
Director |
– • – |
2021-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
27,858 |
28,208 |
0 |
- |
|
| PBYI |
Puma Biotechnology Inc |
Director |
– • – |
2021-06-10 |
4 |
S |
$11.36 |
$292,433 |
D/D |
(25,748) |
350 |
0 |
% |
|
| KURA |
Kura Oncology Inc |
President and CEO |
• • – |
2020-12-23 |
4 |
D |
$0.00 |
$0 |
I/I |
(175,000) |
1,620,017 |
0 |
- |
|
| RNA |
Avidity Biosciences, Inc. |
Director |
– • – |
2020-12-22 |
4 |
A |
$0.00 |
$0 |
I/I |
100,000 |
100,000 |
0 |
- |
|
| RNA |
Avidity Biosciences, Inc. |
Director |
– • – |
2020-12-22 |
4 |
D |
$0.00 |
$0 |
D/D |
(100,000) |
89,618 |
0 |
- |
|
| KURA |
Kura Oncology Inc |
President and CEO |
• • – |
2020-12-01 |
4 |
OE |
$6.15 |
$72,908 |
D/D |
11,855 |
39,951 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
